Itron (NASDAQ:ITRI - Get Free Report) is projected to announce its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of $1.48 per share and revenue of $578.4880 million for the quarter. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS.Parties may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 30, 2025 at 10:00 AM ET.
Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The firm had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. During the same period in the previous year, the company posted $1.21 earnings per share. The company's revenue for the quarter was down .4% on a year-over-year basis. On average, analysts expect Itron to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Itron Stock Performance
Shares of ITRI opened at $132.44 on Thursday. The firm has a market cap of $6.06 billion, a P/E ratio of 22.64, a PEG ratio of 0.73 and a beta of 1.48. Itron has a twelve month low of $90.11 and a twelve month high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The firm's 50 day moving average price is $124.51 and its two-hundred day moving average price is $121.34.
Analysts Set New Price Targets
A number of research firms recently weighed in on ITRI. Wall Street Zen cut Itron from a "buy" rating to a "hold" rating in a research note on Saturday, October 18th. Roth Capital upped their price target on shares of Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Weiss Ratings reiterated a "buy (b)" rating on shares of Itron in a research note on Wednesday, October 8th. Johnson Rice downgraded shares of Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Finally, Zacks Research upgraded Itron from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $138.10.
Read Our Latest Stock Analysis on ITRI
Insider Buying and Selling at Itron
In other Itron news, CFO Joan S. Hooper sold 970 shares of the firm's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $121,550.70. Following the completion of the sale, the chief financial officer directly owned 88,394 shares in the company, valued at approximately $11,076,652.14. This trade represents a 1.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Donald L. Reeves III sold 547 shares of the firm's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $68,544.57. Following the completion of the sale, the senior vice president owned 19,604 shares of the company's stock, valued at approximately $2,456,577.24. This represents a 2.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 3,037 shares of company stock valued at $380,566 over the last 90 days. Insiders own 1.45% of the company's stock.
Institutional Investors Weigh In On Itron
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. grew its stake in shares of Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company's stock worth $46,000 after acquiring an additional 268 shares in the last quarter. M&T Bank Corp grew its position in Itron by 10.0% in the 2nd quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company's stock worth $282,000 after purchasing an additional 194 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock valued at $53,000 after buying an additional 81 shares during the last quarter. Jump Financial LLC bought a new position in shares of Itron in the second quarter valued at approximately $1,609,000. Finally, Cerity Partners LLC increased its position in shares of Itron by 10.2% during the second quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company's stock valued at $715,000 after acquiring an additional 503 shares during the last quarter. 96.19% of the stock is owned by institutional investors.
About Itron
(
Get Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.